Renalytix plc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Renalytix plc (RENXF) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-11-19
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $4.00K.
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $0.00.
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $265.00K.
- Renalytix plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $0.00 10-K · filed 2024-09-30 | |
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $265.00K 10-K · filed 2024-09-30 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 10-K · filed 2023-09-28 |